Resources

179 Resources for

commercialization

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Business Dictionary

Commercialization
the application of business principles to something in order to run it as a business
Commercialization definition on BNET »

BNET Resources

Arizona State University Taps Impress Public Relations to Support Flexible Display Center
PHOENIX -- Impress Public Relations, Inc., an international B2B agency, has been named agency of record for the Flexible Display Center at Arizona State University ("FDC"). The FDC is a partnership of ASU, the U.S. Army and private industry for the purpose of advancing development and commercialization of flexible display...
Tags: agency, Arizona State University, commercialization, electronics, FINANCE, partnership, Strategy, U.S. Army
Research articles 2008-10-27
T-Ray Science, Inc.: Dr. Daryoosh Saeedkia Awarded 2008 Douglas R. Colton Medal for Research Excellence
T-Ray Science, Inc., ("T-Ray", the "Company") an emerging leader in the field of TeraHertz ("THz") research, is pleased to announce that our Chief Technology Officer, Dr. Daryoosh Saeedkia, was awarded the prestigious 2008 Douglas R. Colton Medal for Research Excellence from CMC Microsystems. The Douglas R. Colton Medal for...
Tags: commercialization, Company, Dr., Strategy, University of Waterloo
Research articles 2008-10-16
CytRx Corporation's 45% Owned Affiliate RXi Pharmaceuticals Obtains an Exclusive Worldwide License to Technology for the Oral Delivery of RNAi Therapeutics from the University of Massachusetts Medical School
RXi Plans to Develop Oral rxRNA[TM] Therapeutics for Inflammatory Diseases LOS ANGELES -- CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced that its 45% owned affiliate RXi Pharmaceuticals Corporation has licensed exclusive worldwide rights from the University of Massachusetts Medical...
Tags: commercialization, Company, CytRx Corp., Dr., University of Massachusetts
Research articles 2008-10-15
RXi Pharmaceuticals Obtains an Exclusive Worldwide License to Technology for the Oral Delivery of RNAi Therapeutics from the University of Massachusetts Medical School
Company Plans to Develop Oral rxRNA[TM] Therapeutics for Inflammatory Diseases WORCESTER, Mass. -- RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference RNAi, today announced that it has licensed exclusive worldwide rights from the University of Massachusetts Medical...
Tags: commercialization, University of Massachusetts
Research articles 2008-10-14
Pluristem Therapeutics Announces US$1 Million Sale of Shares at 44% Premium to Market Price
NEW YORK -- Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT) a bio-therapeutics company dedicated to the commercialization of non-personalized allogeneic cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced it has entered into definitive agreements to sell common stock and warrants for aggregate gross proceeds of $1,035,000....
Tags: cell, commercialization, Company, SEC
Research articles 2008-09-23
VIVUS Announces Date of Second Quarter 2008 Financial Results and Conference Call
MOUNTAIN VIEW, Calif. -- VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that it will report financial results for the quarter ended June 30, 2008 after the NASDAQ Market closes on Monday August 4, 2008. The company will conduct...
Tags: commercialization, Nasdaq Stock Market Inc.
Research articles 2008-07-31
Halcyon Products' FireGround Compass(R) Receives Acceptance of Department of Homeland Security's TechSolutions Program
Halcyon Products, Inc. announces that their newly developed product, the FireGround Compass®, has completed the TechSolutions rapid prototyping and operational testing process. The TechSolutions Program recently announced the Halcyon FireGround Compass® as the first product designed by a first responder, to have surpassed the entire TechSolutions development path and...
Tags: commercialization, Engineering, firefighter, Government, MARKETING, PRODUCTIVITY, Regulations, U.S. Department of Homeland Security
Research articles 2008-06-26
Pluristem's President & CEO to be Keynote Speaker at The 4th Annual Stem Cells Asia Congress
NEW YORK -- Pluristem Therapeutics Inc. (NASDAQ: PSTI) (DAX: PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized allogeneic cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced that Mr. Zami Aberman, Pluristem's President & CEO, will be the keynote speaker at the 4th...
Tags: 3D, CEO, commercialization, Company, president, speaker, therapy, U.S. Congress
Research articles 2008-06-23
Turning Pennies into dollars: (Nasdaq: CEGE), (NASDAQ: ACUS), (OTCBB: XDSL).
M2 PRESSWIRE-2 April 2008-RealPennies.com: Turning Pennies into dollars: (Nasdaq: CEGE), (NASDAQ: ACUS), (OTCBB: XDSL).C1994-2008 M2 COMMUNICATIONS LTD RDATE:02042008 Are you a public company looking for exposure? Contact RealPennies.com - 1.800.940.6559 For more info: http://cege.realpennies.com ...
Tags: Cell, Cell Genesys Inc., commercialization, Components, HARDWARE, mPhase Technologies Inc., Nasdaq Stock Market Inc., Processors, Semiconductors, Takeda
Research articles 2008-04-02
Small Cap Stocks to Watch - CEGE, ITMN, IMAX, TWTI.
M2 PRESSWIRE-1 April 2008-SmallCapReview.com: Small Cap Stocks to Watch - CEGE, ITMN, IMAX, TWTIC1994-2008 M2 COMMUNICATIONS LTD RDATE:01042008 To register for the Free SmallCapReview Newsletter and automatically be entered to win a Blackberry Pearl visit http://www.smallcapreview.com/subscribe.htm ...
Tags: Cell, commercialization, Components, FINANCE, HARDWARE, Investment, Nasdaq Stock Market Inc., Processors, Semiconductors, stock
Research articles 2008-04-01
STHG, CEGE, ACUS, XDSL - OTCStockExchange.com Stock Alert.
M2 PRESSWIRE-1 April 2008-otcstockexchange.com: STHG, CEGE, ACUS, XDSL - OTCStockExchange.com Stock AlertC1994-2008 M2 COMMUNICATIONS LTD RDATE:01042008 Rochester, NY -- OTCStockExchange.com's "Stock Watch Alert" this morning are Steadfast Holdings Group, Inc. (Pink Sheets: STHG), Cell Genesys, Inc. (Nasdaq: CEGE), Acusphere Inc....
Tags: Cell, commercialization, Company, Components, DSL, HARDWARE, mPhase Technologies Inc., Nasdaq Stock Market Inc., Processors, Semiconductors, Takeda, TELECOMMUNICATIONS
Research articles 2008-04-01
MTI Announces Filing of Registration Statement
ALBANY, N.Y. -- Mechanical Technology, Incorporated (MTI, Nasdaq: MKTY), a company primarily engaged in the development and commercialization of Mobion([R])off-the-grid portable power solutions, through its subsidiary MTI MicroFuel Cells Inc. MTI Micro, and in the design, manufacture, and sale of test and measurement instruments and systems, through its subsidiary MTI...
Tags: commercialization, FINANCE, SECURITY
Research articles 2008-03-27
DMC, GSB, AKNS, CPLP, DNDN, NSTK Have Also Been Added To Naked Short List Today.
M2 PRESSWIRE-25 March 2008-BUYINS.NET: DMC, GSB, AKNS, CPLP, DNDN, NSTK Have Also Been Added To Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:25032008 BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked...
Tags: AMEX, commercialization, Databases, Dendreon Corp., FINANCE, HARDWARE, Investment, Nasdaq Stock Market Inc., SEC, SECURITY, SOFTWARE, stock, Storage
Research articles 2008-03-25
VIVUS Announces Date of Fourth Quarter and Full Year 2007 Financial Results and Conference Call
MOUNTAIN VIEW, Calif. -- VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that it will report financial results for the quarter and year ended December 31, 2007 after the NASDAQ Market closes on Thursday March 6, 2008. The company...
Tags: commercialization, FINANCE, financial, Nasdaq Stock Market Inc.
Research articles 2008-03-04
ABR, SBR, TWP, AGIX, CNLG, NSTK Have Been Removed From Naked Short List Today.
M2 PRESSWIRE-3 March 2008-BUYINS.NET: ABR, SBR, TWP, AGIX, CNLG, NSTK Have Been Removed From Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:03032008 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short...
Tags: AtheroGenics Inc., commercialization, FINANCE, Investment, Nasdaq Stock Market Inc., NYSE Euronext, SEC, stock
Research articles 2008-03-03
Verenium Awarded U.S. Department of Energy Grant to Speed Enzyme Development for Cellulosic Ethanol Production
To: ENERGY EDITORS Contact: Kelly Lindenboom, Vice President, Corporate Communications of Verenium Corporation, +1-617-674-5335, kelly.lindenboom@verenium.com CAMBRIDGE, Mass., Feb. 27 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next- generation cellulosic ethanol and high-performance specialty enzymes, today announced that it has been awarded one of four...
Tags: biofuel, commercialization, Company, U.S. Department of Energy, Verenium Corp.
Research articles 2008-02-27
Bright Idea: LRC Launches New Program To Support Growth of Lighting-Related Businesses; LRC and Linc team up to create Lighting Technology Greenhouse.
M2 PRESSWIRE-26 February 2008-Rensselaer Polytechnic Institute: Bright Idea: LRC Launches New Program To Support Growth of Lighting-Related Businesses; LRC and Linc team up to create Lighting Technology GreenhouseC1994-2008 M2 COMMUNICATIONS LTD RDATE:26022008 Troy, N.Y. -- The Lighting Research Center...
Tags: Collaboration, commercialization, Groupware, Institute, Nanotechnology, Rensselaer Polytechnic Institute, SOFTWARE, Strategy, team
Research articles 2008-02-26
VIVUS to Present at the 2008 Merrill Lynch Global Healthcare Conference
MOUNTAIN VIEW, Calif. -- VIVUS, Inc. (NASDAQ: VVUS) a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that Leland F. Wilson, President and CEO, will present an overview of the company at the 19th Annual Merrill Lynch Global Pharmaceutical, Biotechnology, and Medical Device Conference...
Tags: commercialization, Merrill Lynch & Co. Inc.
Research articles 2008-02-01
Inspire Announces Its Termination of Bilastine Licensing Agreement
DURHAM, N.C. -- Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that it has exercised its option to terminate the licensing agreement with FAES Farma, S.A. for the U.S. and Canadian development and commercialization of oral bilastine for the treatment of allergic rhinitis. Inspire is terminating the agreement in its entirety,...
Tags: agreement, commercialization, financial, Inspire Pharmaceuticals Inc., termination
Research articles 2008-01-14
IRX Therapeutics to Present at the 26th Annual JP Morgan Healthcare Conference
NEW YORK -- IRX Therapeutics, a privately-held company dedicated to the development and commercialization of novel drugs for the treatment of cancer and viral diseases today announced that John W. Hadden II, President & Chief Executive Officer, will present at the upcoming 26th Annual JP Morgan Healthcare Conference in San...
Tags: cell, commercialization, Company, conference, J.P. Morgan Chase & Co.
Research articles 2008-01-03
advertisement
advertisement